… routine use of molnupiravir in patients with mild to moderate COVID-19 with risk factors for
… and safety. Considering uncertainties about safety and the risk of resistance, Molnupiravir …

… -2021, there were several COVID-19 treatments for patients with mild to moderate disease …
death in patients with COVID-19. We evaluated molnupiravir pharmacokinetics and safety in a …

… The MOVe-OUT (efficacy and safety of molnupiravir [MK-4482] in non-… Molnupiravir is
intended for adult patients diagnosed with COVID-19 through SARS-CoV-2 testing with mild-to-…

… molnupiravir or nirmatrelvir–ritonavir use in hospitalised patients with mild-to-moderate
COVID-19 … Major studies examining the safety and efficacy of molnupiravir include MOVe-IN and …

… that early molnupiravir treatment in asymptomatic or mildly … the safety, tolerability, and
pharmacokinetics of molnupiravir … COVID-19, the optimal dose and safety of molnupiravir were …

… Recently, Molnupiravir was granted authorization for the treatment of mild-to-moderate
COVID-19 in … warranted to support the clinical utility and safety of Molnupiravir against COVID-19. …

… of 1,074,856 outpatients with COVID-19 in Hong Kong showed that molnupiravir use was
asso… A retrospective cohort study of 920 patients with mild-to-moderate COVID-19 who were …

… In this randomized, controlled clinical trial, we evaluated the antiviral efficacy and adverse
events of molnupiravir on patients with mild-to-moderate Omicron variant infection and found a …

… the treatment of mild to moderate COVID-19 in … safety profile and risk of DILI with molnupiravir
and ritonavir-boosted nirmatrelvir in COVID-19 patients amidst the peak of the COVID-19 …

… a clinical trial of molnupiravir in the treatment of mild COVID-19 in an outpatient setting in …
efficacy, virologic and safety outcomes across the molnupiravir clinical programme [36]. The …